Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
Thursday, May 6, 2010 - 12:51
in Health & Medicine
An international team of researchers has discovered molecular evidence that may explain why some women with HER2 over-expressing breast cancer do not respond to drugs designed to target this important molecule.